Purdue Pharma, the maker of OxyContin, has officially dissolved in bankruptcy following a court ruling that approved a criminal sentence and a multi-billion dollar settlement aimed at addressing the opioid crisis. The settlement, amounting to $7.4 billion, will allocate significant funds to various states, with notable payouts including $59 million to Minnesota and $154 million to Michigan. As part of the agreement, Purdue will cease operations and be replaced by a nonprofit successor organization. Families affected by the opioid epidemic express mixed feelings about the settlement, citing a lack of closure despite the financial compensation. Overall, the dissolution marks a significant development in the ongoing efforts to address the widespread impact of opioid addiction across the United States.